Quick Order

Text Size:AAA

AARSD1  Antibody

All AARSD1 Reagents

Reactivity: Human  
Application: ELISA  WB  IF  ICC/IF  
14280-R012-50
14280-R012-100
50 µg 
100 µg 
Add to Cart
  • Slide 1
  • Slide 1
Reactivity: Human  
Application: ELISA  WB  IP  
14280-T52-50
14280-T52-200
14280-T52-100
50 µg 
200 µg 
100 µg 
Add to Cart
  • Slide 1
  • Slide 1
Reactivity: Human  
Application: ELISA  
14280-MM01-50
14280-MM01-200
14280-MM01-100
50 µg 
200 µg 
100 µg 
Add to Cart
    Reactivity: Human  
    Application: ELISA  
    14280-RP01-400
    14280-RP01-200
    14280-RP01-100
    400 µg 
    200 µg 
    100 µg 
    Add to Cart

      Browse AARSD1 Products by

      AARSD1 Related Area

      AARSD1 Related Pathways

        AARSD1 Summary & Protein Information

        AARSD1 Background

        Cofactor: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000305}; ; Note=Binds 1 zinc ion per subunit. {ECO:0000305};
        Subcellular location: Cytoplasm {ECO:0000250}.
        Sequence similarity: Belongs to the class-II aminoacyl-tRNA synthetase family. Alax-L subfamily. {ECO:0000305}.
        General information above from UniProt

        AARSD1 belongs to the class-II aminoacyl-tRNA synthetase family, Alax-L subfamily. AARSD1 binds 1 zinc ion per subunit functions in trans to edit the amino acid moiety from incorrectly charged tRNA(Ala). Four transcript variants have been described for AARSD1: NM_025267.3, NM_001136042.2, NM_001142653.1 and NM_001142654.1. It has been determined that the latter two variants represent a distinct upstream locus, which is now represented by GeneID:100885848 (PTGES3L), while the former two variants represent readthrough transcripts between PTGES3L and this locus (AARSD1). The readthrough locus (PTGES3L-AARSD1) is now represented by GeneID:100885850.

        AARSD1 Alternative Name

        AARSD1 Related Studies

      • Tatham MH, et al. (2011) Comparative proteomic analysis identifies a role for SUMO in protein quality control. Oncogene. 19(17):2120-8.
      • Kim W, et al. (2011) Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 44(2):325-40.
      • Udeshi ND, et al. (2012) Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition. Mol Cell Proteomics. 11(5):148-59.
      • Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"